Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Carr MJ et al. – BK virus reactivation can occur during natalizumab therapy; however, the significance in the absence of renal dysfunction is unclear. The authors propose regular monitoring for BK reactivation or at least for evidence of renal dysfunction in patients receiving natalizumab.

Related Articles

Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis
Multiple Sclerosis, 10/09/09    Relevance Score: 82%

Treatment of multiple sclerosis: role of natalizumab
Neurological Sciences, 11/18/09    Relevance Score: 80%

Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis
Multiple Sclerosis, 10/26/09    Relevance Score: 80%

Multiple sclerosis. Part 2: Ophthalmic issues in MS therapy
Current Opinion in Ophthalmology, 10/29/09    Relevance Score: 77%

Cochlear implantation in a profoundly deaf patient who also suffers from multiple sclerosis - a case study
Cochlear Implants International, 10/27/09    Relevance Score: 69%

Today in Adverse Drug Reactions...keeping you current

Grip strength and cardiovascular drug use in older people: findings from the Hertfordshire Cohort Study
Age and Aging, 12/18/09

Probable levetiracetam-associated depression in the elderly: Two case reports
The American Journal of Geriatric Pharmacotherapy, 12/18/09

Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression
Anesthesiology, 12/17/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address